U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C20H30O
Molecular Weight 286.4516
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 4
Charge 0

SHOW SMILES / InChI
Structure of RETINOL

SMILES

CC(=C/CO)\C=C\C=C(C)\C=C\C1=C(C)CCCC1(C)C

InChI

InChIKey=FPIPGXGPPPQFEQ-OVSJKPMPSA-N
InChI=1S/C20H30O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,21H,7,10,14-15H2,1-5H3/b9-6+,12-11+,16-8+,17-13+

HIDE SMILES / InChI

Molecular Formula C20H30O
Molecular Weight 286.4516
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 4
Optical Activity NONE

Description
Curator's Comment: description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/8801161

Retonol, also known as Vitamin A1, is a vitamin found in food and used as a dietary supplement. It is used to treat and prevent vitamin A deficiency. It is also used to prevent further issues in those who have measles. Retinol is used as a metabolic precursor of retinoic acid to treat skin-related conditions, such as cellulite, skin aging, photodamage.

CNS Activity

Curator's Comment: Evidence indicates that retinol is transported by retinol binding protein across the blood–brain barrier and blood–CSF barrier to the CNS

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: O95237
Gene ID: 9227.0
Gene Symbol: LRAT
Target Organism: Homo sapiens (Human)
Target ID: Q96NR8
Gene ID: 145226.0
Gene Symbol: RDH12
Target Organism: Homo sapiens (Human)
Target ID: Q92781
Gene ID: 5959.0
Gene Symbol: RDH5
Target Organism: Homo sapiens (Human)
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Preventing
Unknown

Approved Use

Unknown
Preventing
Unknown

Approved Use

Unknown
Preventing
Unknown

Approved Use

Unknown
Primary
AQUASOL A

Approved Use

Used to treat and prevent symptoms of vitamin A deficiency such as xerophthalmia and night blindness. Used as a dietary supplement to prevent vitamin A deficiency in patients with GI diseases (e.g., malabsorption syndromes) and those with abnormal storage and transport of vitamin A (e.g., abetalipoproteinemia, protein deficiency, diabetes mellitus, hyperthyroidism, fever, liver disease, cystic fibrosis with hepatic involvement).

Launch Date

1949
Palliative
AQUASOL A

Approved Use

Children with severe measles have been found to have low serum concentrations of vitamin A; WHO and AAP recommend that vitamin A supplements be given to all children with acute measles, regardless of their country of residence.

Launch Date

1949
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Hypervitaminosis A-induced liver fibrosis: stellate cell activation and daily dose consumption.
2006-03
Retinoic acid regulates sex-specific timing of meiotic initiation in mice.
2006-02-21
RPE65 is an iron(II)-dependent isomerohydrolase in the retinoid visual cycle.
2006-02-03
Vitamin A improves Pax3 expression that is decreased in the heart of rats with experimental diaphragmatic hernia.
2006-02
The acute and chronic toxic effects of vitamin A.
2006-02
Comparative ligand-binding analysis of ten human lipocalins.
2006-02
Nonclassical action of retinoic acid on the activation of the cAMP response element-binding protein in normal human bronchial epithelial cells.
2006-02
Role of retinoic acid receptors alpha1 and gamma in the response of murine limbs to retinol in vitro.
2006-01
Renal pathology and retinol status in multiple myeloma patients.
2006-01
Expression of Connexin 43 in the hearts of rat embryos exposed to nitrofen and effects of vitamin A on it.
2006-01
Vitamin A inhibits pancreatic stellate cell activation: implications for treatment of pancreatic fibrosis.
2006-01
Effects of nitrofen and vitamins A, C and E on maturation of cultured human H441 pneumocytes.
2006
The effect of vitamin A on CCl4-induced hepatic injuries in rats: a histochemical, immunohistochemical and ultrastructural study.
2006
Retinal degeneration associated with RDH12 mutations results from decreased 11-cis retinal synthesis due to disruption of the visual cycle.
2005-12-15
Vitamin A status in mice affects the histone code of the phosphoenolpyruvate carboxykinase gene in liver.
2005-12
Retinoid metabolism during development of liver cirrhosis.
2005-11-15
Retinol inhibits the growth of all-trans-retinoic acid-sensitive and all-trans-retinoic acid-resistant colon cancer cells through a retinoic acid receptor-independent mechanism.
2005-11-01
Development of a versatile reporter assay for studies of retinol uptake and metabolism in vivo.
2005-11-01
Megalin-mediated reuptake of retinol in the kidneys of mice is essential for vitamin A homeostasis.
2005-11
Expression of nuclear receptor and target genes in liver and intestine of neonatal calves fed colostrum and vitamin A.
2005-11
Retinol induces permeability transition and cytochrome c release from rat liver mitochondria.
2005-10-30
Acyl coenzyme A dependent retinol esterification by acyl coenzyme A: diacylglycerol acyltransferase 1.
2005-10-15
Vitamin A regulation of BMP4 expression in the male germ line.
2005-10-01
Vitamin A supplementation induces adipose tissue loss through apoptosis in lean but not in obese rats of the WNIN/Ob strain.
2005-10
Regulation of a highly specific retinoic acid-4-hydroxylase (CYP26A1) enzyme and all-trans-retinoic acid metabolism in human intestinal, liver, endothelial, and acute promyelocytic leukemia cells.
2005-10
Comparison of indices of vitamin A status in children with chronic liver disease.
2005-10
Transmembrane protein GDE2 induces motor neuron differentiation in vivo.
2005-09-30
Mutation of key residues of RPE65 abolishes its enzymatic role as isomerohydrolase in the visual cycle.
2005-09-20
Hypervitaminosis A resulting in DNA aberration in fetal transgenic mice (Muta Mouse).
2005-09-05
Expression of keratinocyte transglutaminase in cornea of vitamin A-deficient rats.
2005-09
beta-cryptoxanthin stimulates cell differentiation and mineralization in osteoblastic MC3T3-E1 cells.
2005-08-15
Fortification of maize meal improved the nutritional status of 1-3-year-old African children.
2005-08
Effects of prenatal vitamins A, E, and C on the hypoplastic hearts of fetal rats with diaphragmatic hernia.
2005-08
Phospho-STAT5 accumulation in nuclear fractions from vitamin A-deficient rat liver.
2005-07-04
Serum and CSF vitamin A concentrations in idiopathic intracranial hypertension.
2005-06-14
Effect of vitamin A content in cafeteria diet on the expression of nuclear receptors in rat subcutaneous adipose tissue.
2005-06
Vitamin a deficiency and anaemia in young children living in a malaria endemic district of western Kenya.
2005-06
Vitamin A deficiency induces prooxidant environment and inflammation in rat aorta.
2005-06
Inhibitory effects of vitamin A on TCDD-induced cytochrome P-450 1A1 enzyme activity and expression.
2005-05
Alcohol, vitamin A, and cancer.
2005-04
Brain tissue fragments in the amniotic fluid of rats with neural tube defect.
2005-04
What is the safe dose of vitamin A in children with measles?
2005-04
Retinoid receptor mRNA expression profiles in human bladder cancer specimens.
2005-04
Extra-hepatic vitamin A concentrations in captive Rhesus (Macaca mulatta) and Marmoset (Callithrix jacchus) monkeys fed excess vitamin A.
2005-03
Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months.
2005-03
Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on vitamin A metabolism in mice.
2005
Protein and m-RNA expression of farnesyl-transferases, RhoA and RhoB in rat liver hepatocytes: action of perillyl alcohol and vitamin A in vivo.
2005
Differential effects of vitamin A on fetal lung growth and diaphragmatic formation in nitrofen-induced rat model.
2005
Age differences in vitamin A intake among Canadian Inuit.
2004-12-30
Use of the deuterated-retinol-dilution technique to monitor the vitamin A status of Nicaraguan schoolchildren 1 y after initiation of the Nicaraguan national program of sugar fortification with vitamin A.
2004-11
Patents

Sample Use Guides

Weekly single oral dose 7000 micrograms
Route of Administration: Oral
The role of vitamin A (2.72 μM/7 ml culture), a naturally occurring antioxidant upon arsenic-induced genotoxicity; with respect to chromosomal aberrations (structural and numerical) and micronuclei. Whole blood cultures set for 72 h were exposed to test chemicals for a period of 24 h ahead of harvesting. Arsenic concentrations tested in the present study are 0.36, 0.72 and 1.4 μM/7 ml culture. Mitomycin C (MMC), the direct acting mutagen was used as positive control.
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:12:19 GMT 2025
Edited
by admin
on Mon Mar 31 18:12:19 GMT 2025
Record UNII
G2SH0XKK91
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NSC-122759
Preferred Name English
RETINOL
HSDB   INCI   INN   WHO-DD  
INN   INCI  
Official Name English
Retinol [WHO-DD]
Common Name English
VITAMIN A ALCOHOL
Common Name English
(2E,4E,6E,8E)-3,7-DIMETHYL-9-(2,6,6-TRIMETHYLCYCLOHEX-1-EN-1-YL)NONA-2,4,6,8-TETRAEN-1-OL
Systematic Name English
ALL-TRANS-RETINOL
Common Name English
retinol [INN]
Common Name English
VITAMIN A [MI]
Common Name English
RETINOL [HSDB]
Common Name English
Classification Tree Code System Code
WHO-VATC QR01AX02
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
LOINC 20947-8
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
LOINC 14905-4
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
WHO-VATC QS01XA02
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
NCI_THESAURUS C68299
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
NCI_THESAURUS C938
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
WHO-VATC QD10AD02
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
WHO-ESSENTIAL MEDICINES LIST 27
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
LOINC 20948-6
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
DSLD 3441 (Number of products:6)
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
WHO-ATC S01XA02
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
WHO-ATC A11CA01
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
EU-Orphan Drug EU/3/17/1895
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
LOINC 20946-0
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
LOINC 87673-0
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
LOINC 2923-1
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
WHO-ATC D10AD02
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
WHO-ATC R01AX02
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
WHO-VATC QA11CA01
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
LOINC 2922-3
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
Code System Code Type Description
DRUG CENTRAL
2831
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
PRIMARY
EPA CompTox
DTXSID3023556
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
PRIMARY
CHEBI
45479
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
PRIMARY
CAS
68-26-8
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
PRIMARY
RXCUI
1367187
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
PRIMARY RxNorm
PUBCHEM
445354
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
PRIMARY
DRUG BANK
DB00162
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
PRIMARY
HSDB
815
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
PRIMARY
ChEMBL
CHEMBL986
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
PRIMARY
CHEBI
50211
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
PRIMARY
INN
2243
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
PRIMARY
SMS_ID
100000076424
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
PRIMARY
WIKIPEDIA
RETINOL
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
PRIMARY
FDA UNII
G2SH0XKK91
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
PRIMARY
CHEBI
17336
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
PRIMARY
ECHA (EC/EINECS)
200-683-7
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
PRIMARY
EVMPD
SUB16102MIG
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
PRIMARY
NCI_THESAURUS
C68302
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
PRIMARY
DAILYMED
G2SH0XKK91
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
PRIMARY
NSC
122759
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
PRIMARY
MERCK INDEX
m11481
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
PRIMARY Merck Index
Related Record Type Details
ACTIVE MOIETY